| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Henry E. Pelish | Chief Scientific Officer | 2026-03-13 | 2,597 | $98.83 | $256.66kSell |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-13 | 804 | $97.89 | $78.70kSell |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-13 | 1,703 | $99.71 | $169.81kSell |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-12 | 1,754 | $27.85 | $48.85kBuy |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-12 | 8,456 | $18.93 | $160.07kBuy |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-12 | 306 | $99.12 | $30.33kSell |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-12 | 5,505 | $98.44 | $541.91kSell |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-12 | 24,189 | $97.79 | $2.37MSell |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-12 | 2,985 | $72.35 | $215.96kBuy |
| Henry E. Pelish | Chief Scientific Officer | 2026-03-12 | 4,125 | $29.33 | $120.99kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 22.77% | 17,903,448 | $1.77B | Insider |
| Deerfield Management Company LP | 21.94% | 17,248,450 | $1.71B | Institution |
| Fmr LLC | 13.80% | 10,852,884 | $1.07B | Institution |
| Paradigm Biocapital Advisors LP | 6.70% | 5,269,433 | $521.52M | Institution |
| Vanguard Group Inc | 6.67% | 5,244,271 | $519.03M | Institution |
| Blackrock Inc | 6.11% | 4,805,261 | $475.58M | Institution |
| Wellington Management Group LLP | 3.13% | 2,461,823 | $243.65M | Institution |
| Jpmorgan Chase Co | 2.81% | 2,205,251 | $218.25M | Institution |
| Price T Rowe Associates Inc | 2.73% | 2,146,938 | $212.48M | Institution |
| Ra Capital Management LP | 2.39% | 1,880,057 | $186.07M | Institution |